携带者筛查残余风险评估的挑战
本文讨论隐性遗传病携带者筛查中残余风险的计算与临床应用挑战。由于人群发病率、变异频率及祖源归属的不确定性,精确残余风险难以获得且可能不适用于个体;作者建议告知患者当代筛查漏检的携带者比例很小,残余风险远低于侵入性产前诊断风险,无需追求精确残余风险。
要点
- 残余风险基于人群携带频率减去检测到的致病变异频率计算,但人群数据常不准确或缺失。
- 祖源错配和未知混合使群体特异性残余风险难以适用于个体。
- 当代携带者筛查的残余风险远低于侵入性产前诊断风险,无需提供精确残余风险。
核心结论
- 精确残余携带风险因数据缺失、祖源不确定及缺乏管理影响证据而难以提供,且无必要。
- 应告知患者携带者筛查可能漏检少量携带者,但残余风险远低于侵入性产前诊断风险。
研究设计与样本
- 本文为综述/观点类文章,讨论携带者筛查中残余风险的计算与咨询挑战,未报告系统检索范围或样本量。
主要发现
- 许多隐性遗传病的发病率及携带频率在不同人群间存在差异,且对全球多数人群的许多基因不准确或不可获得。
- 检测到的致病变异及其频率随时间和人群变化,需持续更新残余风险。
- 即使使用准确数据得出的残余风险,也可能因祖源错配或未知混合而不适用于个体。
关键数值与推荐
- 残余风险计算为人群携带频率减去检测到的致病变异携带频率,人群携带频率由疾病发病率估算。
- 当代携带者筛查的残余风险远低于侵入性产前诊断的风险,即使夫妇一方为携带者。
临床怎么用
- 向患者说明携带者筛查可能漏检少量携带者,但残余风险很低。
- 无需为患者提供精确的残余携带风险数值。
局限性
- 缺乏数据说明残余风险影响临床管理。
- 人群发病率与变异频率数据不准确或缺失,祖源归属不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The probability an individual is a carrier for a recessive disorder despite a negative carrier test, referred to as residual risk, has been part of carrier screening for over 2 decades. Residual risks are calculated by subtracting the frequency of carriers of pathogenic variants detected by the test from the carrier frequency in a population, estimated from the incidence of the disease. Estimates of the incidence (and therefore carrier frequency) of many recessive disorders differ among different population groups and are inaccurate or unavailable for many genes on large carrier screening panels for most of the world's populations. The pathogenic variants detected by the test and their frequencies also vary across groups and over time as variants are newly discovered or reclassified, which requires today's residual carrier risks to be continually updated. Even when a residual carrier risk is derived using accurate data obtained in a particular group, it may not apply to many individuals in that group because of misattributed ancestry or unsuspected admixture. Missing or inaccurate data, the challenge of determining meaningful ancestry-specific risks and applying them appropriately, and a lack of evidence they impact management, suggest that patients be counseled that although carrier screening may miss a small fraction of carriers, residual risks with contemporary carrier screening are well below the risk posed by invasive prenatal diagnosis, even if one member of the couple is a carrier, and that efforts to provide precise residual carrier risks are unnecessary.
引用
- Nussbaum RL, Slotnick RN, Risch NJ, et al. Challenges in providing residual risks in carrier testing. Prenat Diagn. 2021. PMID: 34057205. doi:10.1002/pd.5975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。